Kiora Pharmaceuticals (KPRX) Earnings Date & Reports
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
KPRX is expected to report earnings to fall 12.07% to -50 cents per share on August 07
Q2'26
Est.
$-0.51
Q1'26
Missed
by $0.09
Q4'25
Missed
by $1.50
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.48
The last earnings report on May 08 showed earnings per share of -57 cents, missing the estimate of -49 cents. With 23.78K shares outstanding, the current market capitalization sits at 11.30M.